The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study

Ak, Naziye; Ozkan, Berker; Yenigun, Mustafa; Yilmazbayhan, Dilek; Toker, Alper; Ferhatoglu, Ferhat; Yasar, Arzu; SAK, SERPİL; Tanju, Serhan; Dilege, Sukru; Erus, Suat; Bulutay, Pinar; Firat, Pinar; Mandel, Nil; Kilickap, Sadettin; Onder, Sevgen; DİKMEN, ERKAN; Alan, Ozkan; YUMUK, PERRAN; BOZKURTLAR, EMİNE; LAÇİN, TUNÇ; YILDIZELİ, BEDRETTİN; Ozturk, Akin; Kocaturk, Celalettin; Karapinar, Kemal; Urer, Nur; OYAN ULUÇ, Başak; Aydiner, Adnan; DEMİRKAZIK, AHMET; Eralp, Yesim

The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study

Atıf İçin Kopyala

Ak N., Ozkan B., Yenigun M. B., Yilmazbayhan D., Toker A., Ferhatoglu F., ...Daha Fazla

JOURNAL OF BUON, cilt.26, sa.3, ss.819-829, 2021 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 26 Sayı: 3
Basım Tarihi: 2021
Dergi Adı: JOURNAL OF BUON
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
Sayfa Sayıları: ss.819-829
Marmara Üniversitesi Adresli: Evet

Özet

Purpose: The benefit of adjuvant chemotherapy for tumors smaller than 4 cm is not clear. We aimed to evaluate the prognostic impact of adjuvant platin-based chemotherapy in high-risk stage I patients with non-small cell lung cancer (NSCLC).